Skip to content

Author

Houra Nekounam

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Different functionalized nanocarriers for improvement of gene delivery.

Gene delivery is a highly advanced therapeutic approach that involves the introduction of therapeutic nucleic acids, including DNA and RNA, into target cells to restore, regulate or enhance cellular function. Delivery vectors are a critical determinant of gene therapy efficacy and are generally classified as either viral or non-viral. Viruses vectors are often transfection efficient, but the clinical applications are limited by concerns such as immunogenicity, limited cargo capacity and manufacturing complexity. In contrast, non-viral vectors provide higher safety, structural versatility and ease of production but often have lower delivery efficiency and encounter various extracellular and intracellular barriers. Recent advances in nanotechnology have enabled the development of a variety of nanocarriers that can partially overcome these limitations and improve the performance of gene transfer. Protection of nucleic acids from degradation, selective delivery to target cells with minimal uptake by healthy tissues, efficient cellular internalization and intracellular release of the genetic cargo are among the major challenges in gene delivery. Functionalization of nanocarriers is a promising strategy to overcome these barriers, enhancing nucleic acid loading, colloidal stability, biocompatibility, targeting ability, endosomal escape and overall transfection efficiency. This review summarizes the different functionalized nanocarriers for gene delivery such as silica-based nanoparticles, gold nanoparticles, magnetic nanoparticles, graphene-based materials, carbon nanotubes, polycationic systems, and lipidic nanostructures. Special emphasis is placed on the role of surface functional groups and ligands in modulating biological performance and overcoming delivery barriers. The studies reviewed here all show that functionalized nanocarriers are generally better than their non-functionalized counterparts, but their effectiveness strongly depends on the composition of the nanocarrier, the surface chemistry, the nature of the cargo and the context of the target cell. Overall, functionalized nanostructures are promising platforms for improving the safety and efficiency of non-viral gene delivery. .

Houra Nekounam, Ali Karbalaeimahdi, Faranak Mohammadi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.